The prescription pills, sold under the brand name Journavx and made by Vertex Pharmaceuticals, are taken twice a day and ...

The FDA has approved Journavx, an oral medication for treating pain that doesn't target the brain like addictive opioids.

The drug, Journavx by Vertex Pharmaceuticals, blocks pain signals to the brain, making it nonaddictive. The Food and Drug ...

U.S. officials have approved a new type of pain drug designed to eliminate the risks of addiction and overdose associated ...

The drug, suzetrigine, is a 50-milligram prescription pill that’s taken every 12 hours after a larger starter dose. It will be sold under the brand name Journavx. “A new non-opioid analgesic ...

The medication will be sold under the brand name Journavx ... the drug’s development and review underscore FDA’s commitment to approving safe and effective alternatives to opioids for pain ...

FDA approves new type of non-opioid pain medication in two decades - The new drug will be many times more expensive than a ...

The drug, suzetrigine, will be sold under the brand name Journavx and is the first new ... said in a statement. “A new non-opioid analgesic therapeutic class for acute pain offers an opportunity ...

offers a non-opioid alternative for pain management. While the company asserts that the cost is in line with other brand-name pain medications, some experts, as reported by USA TODAY, have raised ...

The new product will launch at a list price of $15.50 per 50mg ... arguing that the drug will be less likely to lead to opioid use disorder (OUD) than opioid-based painkillers like oxycodone ...

With opioid prescriptions plummeting and no more pharma companies to sue, America's drug warriors are running out of bogeymen ...